RXO’s stock price was pummeled Wednesday after the release of its earnings The post In a weak quarter for brokerages, RXO’s stock price takes a pounding after earnings appeared first on FreightWaves.
Under Armour (NYSE:UAA) Delivers Impressive Q4, Stock Soars
Athletic apparel company Under Armour (NYSE:UAA) reported Q4 CY2024 results beating Wall Street’s revenue expectations, but sales fell by 5.7% year on year to $1.40 billion. Its non-GAAP profit of $0.08 per share was significantly above analysts’ consensus estimates.
5 Things to Know Before the Stock Market Opens
News of the day for Feb. 6, 2025
Philip Morris (NYSE:PM) Surprises With Q4 Sales, Stock Soars
Tobacco company Philip Morris International (NYSE:PM) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 7.3% year on year to $9.71 billion. Its non-GAAP profit of $1.55 per share was 3.4% above analysts’ consensus estimates.
Honeywell Announces Three-Way Split, Stock Falls
Honeywell International, the storied conglomerate which launched a strategic review early last year, announced plans Thursday to split into three independent companies.
Fed releases 2025 stress test scenarios
The stress test, which will include 22 banks compared to last year’s 32, will feature two added hypothetical elements for the Fed’s “exploratory analysis” of the banking system.
Peloton’s (NASDAQ:PTON) Q4 Sales Beat Estimates, Stock Jumps 12.5%
Exercise equipment company Peloton (NASDAQ:PTON) announced better-than-expected revenue in Q4 CY2024, but sales fell by 9.4% year on year to $673.9 million. On the other hand, next quarter’s revenue guidance of $615 million was less impressive, coming in 6% below analysts’ estimates. Its GAAP loss of $0.24 per share was 25.9% below analysts’ consensus estimates.
Tapestry (NYSE:TPR) Posts Better-Than-Expected Sales In Q4, Stock Jumps 14.6%
Luxury fashion conglomerate Tapestry (NYSE:TPR) announced better-than-expected revenue in Q4 CY2024, with sales up 5.3% year on year to $2.20 billion. The company’s full-year revenue guidance of $6.85 billion at the midpoint came in 1.4% above analysts’ estimates. Its GAAP profit of $1.38 per share was 12.7% below analysts’ consensus estimates.
Omnicell (NASDAQ:OMCL) Exceeds Q4 Expectations But Full-Year Sales Guidance Misses Expectations
Healthcare tech company Omnicell (NASDAQ:OMCL) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 18.6% year on year to $306.9 million. On the other hand, next quarter’s revenue guidance of $260 million was less impressive, coming in 2% below analysts’ estimates. Its non-GAAP profit of $0.60 per share was 2.8% above analysts’ consensus estimates.
Q4 freight data shows market reboot slower than anticipated
Q4 2024 data released by freight audit and payment provider U.S. Bank showed a trucking industry continuing to battle cyclical and structural headwinds. The post Q4 freight data shows market reboot slower than anticipated appeared first on FreightWaves.